InvestorsHub Logo

Canoepaddler

02/15/16 1:24 PM

#13109 RE: Rogerthat1 #13104

Really good information Rogerthat. The quality of information and posts here just today is terrific. I am more excited than ever about TPIV. Thanks again for sharing.

toomorrow

02/15/16 3:22 PM

#13112 RE: Rogerthat1 #13104

Thank you for asking those questions and posting the responses! Lots of good things happening for TPIV this year. Very exciting times for this company.

rnoutlaw21

02/15/16 5:05 PM

#13113 RE: Rogerthat1 #13104

Thanks for posting this. Can you tell us the date he provided the response?

Cre8tivmynd

02/16/16 9:21 AM

#13131 RE: Rogerthat1 #13104

Roger..Was Glynn's response to your questions?

GreenMan

02/16/16 10:15 AM

#13138 RE: Rogerthat1 #13104

Nice. Thanks for the update.

Canoepaddler

02/24/16 10:15 PM

#13397 RE: Rogerthat1 #13104

Good information for those that have not seen this!

LaJollaCA

02/25/16 1:04 AM

#13400 RE: Rogerthat1 #13104

You typed this up yourself?

Canoepaddler

02/26/16 8:47 PM

#13485 RE: Rogerthat1 #13104

Post #13104 for new investors to check out doing DD over the weekend.

lasers

02/27/16 7:07 AM

#13493 RE: Rogerthat1 #13104

Rogerthat1 With other FDA Cancer drugs that I follow, either the Pharma or the Cancer Clinic, or both, pays for the entire Clinical Trials costs and almost always in return for acquiring licensing rights when the Combo is granted FDA Commercial approval. These trials are usually Pivotal P2B or P3.

This would be a win-win for a young biotech like $TPIV assuming this to be the case.